<DOC>
	<DOCNO>NCT02411513</DOCNO>
	<brief_summary>The purpose study investigate efficacy e-TNS Cefaly® device acute treatment migraine attack . This open clinical trial study acute treatment migraine use Cefaly® device , prior development sham-controlled trial .</brief_summary>
	<brief_title>Acute Treatment Migraine Using CEFALY Device</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Patient history episodic chronic migraine without aura , meet diagnostic criterion list ICHDIII beta ( 2013 ) section 1 , migraine ( 1 ) , exception `` complicate migraine '' ( i.e. , hemiplegic migraine , migraine brainstem aura , ophthalmoplegic migraine recurrent painful ophthalmoplegic neuropathy , migrainous infarction ) The patient must experience migraine attack last least 3 hour , pain intensity stabilize least 1 hour . The location headache frontal , retro peri orbital , one either side . Pregnant woman Patients receive treatment onabotulinum toxin ( e.g. , Botox , Dysport , Xeomin ) head prior 4 month Patients receive supraorbital nerve block prior 4 month Diagnosis primary secondary headache disorder , except Medication Overuse Headache Patients temporal occipital headache Patients take opioid medication Patients take abortive migraine medication prior 3 hour Allodynia : intolerance supraorbital neurostimulation ( allodynia ) make treatment applicable ( patient exclude neurostimulation already start ) . Implanted metal electrical device head Cardiac pacemaker implant wearable defibrillator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>